Environmental and Human Impacts of Nuclear Weapons Testing: A Global Perspective

The paper examines the environmental and human-health impacts generated by nuclear weapons testing conducted since 1945, with a focus on atmospheric and oceanic contamination and pathways of human exposure. Against the geopolitical backdrop of the Cold War and subsequent proliferation outside the NPT regime, nuclear testing by recognized nuclear-weapon states and nuclear-armed states led to widespread dispersion of radionuclides. The study’s purpose is to synthesize evidence on global and regional contamination patterns, characterize key radionuclides and their environmental behavior, and assess health implications—particularly thyroid cancer linked to 131I—using a U.S. case study. The work underscores the importance of understanding long-term radioactive legacies that persist decades after major test bans (LTBT, CTBT) due to the longevity and mobility of certain radionuclides.

The paper situates its analysis within established bodies of work and datasets: test counts and timelines from SIPRI and CTBTO; dose and yield estimates from UNSCEAR reports (1982, 1993, 2000, 2006); atmospheric and marine radiocarbon studies (e.g., Levin et al., Manning and Melhuish, Scourse et al.); marine radioactivity syntheses and databases (IAEA TECDOCs, GLOMARD); assessments of contamination and exposure at major test sites (IAEA reports on Semipalatinsk, Bikini, Moruroa/Fangataufa, Algeria); and epidemiological analyses of thyroid cancer risks following fallout (NCI reports; Gilbert et al.; Takahashi et al.). The review also references nuclear accident literature (Chernobyl, Fukushima) to contextualize additional anthropogenic sources affecting hemispheric burdens, and draws on work regarding fallout deposition mechanisms, soil-to-plant transfer, riverine transport to seas, and biota accumulation.

The study conducts a synthetic assessment using multiple established datasets and published analyses: (1) Global spatiotemporal patterns of nuclear testing compiled from SIPRI and CTBTO sources, distinguishing atmospheric, underground, and underwater tests and associated yields (UNSCEAR). (2) Dose modeling and radionuclide contributions to collective effective dose commitments from atmospheric tests using UNSCEAR frameworks, including both full-term (millennia) and truncated (to year 2200) commitments to compare the relative importance of 14C versus shorter-lived nuclides (e.g., 137Cs, 90Sr). (3) Time series of atmospheric 14C from monitoring stations representative of both hemispheres (Vermunt, Austria; Wellington, New Zealand) and comparison with marine surface 14C reconstructions from biogenic archives (Arctica islandica) for the North Atlantic. (4) Marine radioactivity assessments drawing on IAEA datasets and regional studies to map 137Cs levels, sources (global/local fallout, reprocessing plants, accidents), and temporal trends. (5) Site-specific contamination reviews for major test sites (Nevada Test Site; Semipalatinsk; Novaya Zemlya; Pacific atolls including Bikini/Enewetak and Moruroa/Fangataufa; Lop Nur; Algerian sites), summarizing environmental media affected, dominant radionuclides, and indicative dose estimates for hypothetical resident groups. (6) U.S. case study linking atmospheric circulation (NCEP/NCAR reanalysis winds at 700/400/200 mb for 1951–1958), NCI-modeled 131I ground deposition, milk-distribution pathways, and per-capita cumulative thyroid doses by state, juxtaposed with state cancer registry incidence trends for thyroid cancer by sex to explore associations. The approach is integrative and descriptive, relying on published measurements, modeled reconstructions, maps, and official assessments rather than new primary sampling.

• Scope of testing and yields: 2053 nuclear tests were conducted worldwide (1945–2006); ~85% by the USA and USSR, ~14.5% by the UK, France, and China, and <1% by India, Pakistan, and DPRK. About 25% (≈530 tests) were atmospheric/underwater; 75% (≈1517) underground. Total yield (1951–1992) ≈530 Mt TNT equivalent: 83% (≈440 Mt) atmospheric (1951–1980), 17% (≈90 Mt) underground (1962–1992). Of atmospheric yield, ≈57% fusion (≈251 Mt) and 43% fission (≈189 Mt). By country yields: USSR ≈285 Mt, USA ≈200 Mt, China ≈22 Mt, France ≈13 Mt, UK ≈10 Mt.
• Hemispheric contamination: ~90% of tests occurred in the Northern Hemisphere, producing higher burdens of radionuclides (notably 14C, 137Cs, 90Sr); additional northern contamination from major reactor accidents (Chernobyl 1986, Fukushima 2011).
• Collective dose contributions from atmospheric testing (UNSCEAR 1993): Total effective dose commitment ≈3700 µSv to the world population, with 14C contributing ~70% (≈2580 µSv) over millennia. In a truncated horizon to year 2200 (10% of 14C dose considered), 137Cs contributes ~35%, 14C ~19%, 90Sr ~8.1%, with several other radionuclides contributing smaller fractions.
• 14C dynamics: Atmospheric 14C peaked in 1964–1965 following thermonuclear tests, with higher and earlier peak in the Northern Hemisphere (Vermunt peak ≈835‰ in 1964) versus Southern Hemisphere (Wellington peak ≈642‰ in 1965), then declined steadily. Marine surface 14C in the North Atlantic peaked later (≈1974) with attenuated amplitude due to oceanic reservoir size and mixing, indicating sustained air–sea transfer.
• Marine radioactivity (137Cs as key tracer): Around 2000, most marine regions had 137Cs concentrations of ~1–10 Bq/m3, with higher levels in the Northeastern Atlantic (Irish/North Seas), Barents, Baltic, and Black Seas (>10 Bq/m3), reflecting combined inputs from fallout, reprocessing (Sellafield, La Hague), and accidents (Chernobyl). Baltic Sea exhibited the highest averages (~100 Bq/m3). Declines observed in many regions (e.g., Barents Sea from ~40 Bq/m3 in 1979 to ~10 Bq/m3 in 2000).
• 90Sr behavior: Dominant wet deposition pathway (~90% of total for 90Sr and 137Cs). Riverine transport is an important mechanism to seas, particularly in the Pacific basin. Regional decreases over recent decades noted (e.g., Kara Sea surface waters from ~39 Bq/m3 in 1963 to ~5 Bq/m3 in 1994).
• Major contaminated sites and impacts: • Nevada Test Site (USA): Significant atmospheric releases of 131I (≈150 MCi, 99% from Nevada atmospheric tests, mainly 1951–1958). Risks include venting from some underground tests and potential groundwater transport of actinides (e.g., 239–240Pu). • Semipalatinsk (Kazakhstan): High contamination by 90Sr, 137Cs, 239–240Pu, 241Am in soils/vegetation; elevated U isotopes in well water (>15 µg/L WHO guideline). Annual effective dose for frequent visitors estimated ~10 mSv; hypothetical permanent settlement ~140 mSv/year. Additional fallout from Chinese Lop Nur tests contributed radionuclides (137Cs, Ru-106/103, Ce-141/144, Zr-95) and may be linked to increased regional cancer incidence. • Novaya Zemlya (Russia): ~130 tests (~70% atmospheric); major local contamination by 137Cs and 239–240Pu (notably in marine waters). Site of 50 Mt Tsar test (1961). • Pacific atolls (USA): Castle Bravo (Bikini, 1954) caused severe local and regional contamination; extreme absorbed doses up to ~6 Gy (e.g., Lucky Dragon crew). Ongoing contamination patterns include 137Cs in water/sediments/biota, 90Sr in coral soils, and 239,240Pu/241Am in sediments. Hypothetical annual effective dose for Bikini residents relying on local foods ~15 mSv (excluding natural background); with background ~17.4 mSv. • French Polynesia (France): Moruroa (179 tests; 42 atmospheric, 137 underground) and Fangataufa (14 tests; 4 atmospheric, 10 underground); key radionuclides include 238,239,240Pu (dominant), with lesser contributions from 3H, 90Sr, 137Cs, 241Am, 125Sb. Human exposure from plutonium deemed negligible due to low transfer; hypothetical annual dose in Fangataufa hotspot ~0.25 mSv. Increased thyroid cancer incidence reported in regional populations, linked to radioiodine ingestion. • Algeria (France): Reggane and Ekker tests (1960–1966) led to contamination of desert sands with 239–240Pu, 137Cs, 90Sr; primary exposure via inhalation/ingestion of contaminated dust.
• Human health—U.S. thyroid cancer case study: Atmospheric circulation (west–east winds, 1951–1958) facilitated long-range dispersion of 131I to U.S. states, with deposition patterns decoupled from population doses due to milk-production and distribution networks and age-specific consumption. Highest average per-capita cumulative thyroid doses (>90 mGy) occurred in Idaho, Montana, Utah, Colorado, and South Dakota; nine additional states exceeded 60 mGy. Substantial increases in thyroid cancer incidence observed over recent decades, especially among females, in multiple states (e.g., Utah: ~10 to 29.4 per 100,000 from 1990 to 2009; Idaho: ~8.5 to 26.1 per 100,000 from 1999 to 2010; Wyoming and Iowa also rising). While 131I exposure is a key risk factor, other contributors (medical radiation, diagnostic/therapeutic practices) complicate attribution.

The findings demonstrate that nuclear weapons testing produced widespread, long-lived environmental contamination, particularly in the Northern Hemisphere, through atmospheric releases that loaded global reservoirs with radionuclides. The analysis shows that although atmospheric tests ceased decades ago, radionuclides with varying half-lives continue to shape exposure profiles: short- to medium-lived fission products (137Cs, 90Sr) dominated population doses over the first centuries post-testing, while 14C contributes the majority of collective dose over millennial horizons due to its integration into the carbon cycle and vast environmental reservoirs. The ocean’s role as the largest sink moderated atmospheric radiocarbon levels yet introduced bioaccumulation pathways affecting marine food webs. Site-specific assessments reveal that legacy contamination persists in soils, sediments, and groundwater, with localized dose risks for hypothetical or occasional occupants, and that marine areas near test sites or reprocessing discharges experienced elevated radionuclide inventories that have declined but not vanished. The U.S. case study links atmospheric transport, fallout deposition, and food chain pathways (notably milk) to geographically variable thyroid doses and subsequent increases in thyroid cancer incidence, supporting a causal role for 131I while acknowledging significant co-factors from evolving medical exposures. Overall, the results emphasize the enduring nature of nuclear-test legacies, the importance of environmental media interactions (atmosphere–ocean–biosphere), and the need to consider both global background and local hotspots in risk assessment and management.

Nuclear testing in the latter half of the twentieth century, driven by geopolitical competition and status signaling, produced substantial and persistent ecological and social impacts. Critical terrestrial and marine test sites remain contaminated, with key radionuclides—137Cs, 90Sr, 239–240Pu, 241Am, and 131I—responsible for much of the environmental burden and human irradiation risk. The ocean has buffered atmospheric burdens (e.g., 14C) but created bioaccumulation pathways in marine biota. In human health terms, increased thyroid cancer incidence in affected regions, illustrated by the U.S. case study, likely reflects contributions from 131I exposure superimposed on other risk trends (notably medical radiation). Future work should prioritize: continued monitoring of legacy sites and surrounding marine areas; refinement of dose-reconstruction models (including food-chain and trade/transport pathways); assessment of groundwater contamination and migration at underground test sites; evaluation of long-term ecological effects of low-dose chronic exposures; and integrated epidemiological studies disentangling nuclear-test exposures from other radiation sources. Enhanced international data sharing and remediation where feasible can mitigate remaining risks.

The synthesis relies on secondary datasets and prior assessments (UNSCEAR, IAEA, NCI, SIPRI/CTBTO), which carry uncertainties in historical yields, deposition, and dose reconstructions. Spatial and temporal coverage varies among measurements (e.g., atmospheric 14C series end dates, regional marine sampling), and modeled quantities (e.g., truncated dose commitments, thyroid dose maps) depend on assumptions about population behaviors (diet, milk distribution), environmental transfer coefficients, and demographic projections. Site-specific dose estimates for hypothetical groups may not reflect current actual exposures. In the U.S. case study, attribution of thyroid cancer trends to 131I is confounded by increased medical imaging and therapeutic radiation, changes in diagnostic intensity, and registry practices. Additionally, contributions from nuclear accidents (Chernobyl, Fukushima) and reprocessing discharges complicate source apportionment in some regions.